IL217934A - Non-cross-reactive anti igg antibodies - Google Patents
Non-cross-reactive anti igg antibodiesInfo
- Publication number
- IL217934A IL217934A IL217934A IL21793412A IL217934A IL 217934 A IL217934 A IL 217934A IL 217934 A IL217934 A IL 217934A IL 21793412 A IL21793412 A IL 21793412A IL 217934 A IL217934 A IL 217934A
- Authority
- IL
- Israel
- Prior art keywords
- cross
- igg antibodies
- reactive anti
- anti igg
- reactive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09013144 | 2009-10-19 | ||
| PCT/EP2010/065617 WO2011048043A1 (en) | 2009-10-19 | 2010-10-18 | NON-CROSS-REACTIVE ANTI IgG ANTIBODIES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL217934A0 IL217934A0 (en) | 2012-03-29 |
| IL217934A true IL217934A (en) | 2015-04-30 |
Family
ID=41834476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL217934A IL217934A (en) | 2009-10-19 | 2012-02-05 | Non-cross-reactive anti igg antibodies |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9957331B2 (en) |
| EP (1) | EP2491397B1 (en) |
| JP (2) | JP5715634B2 (en) |
| KR (1) | KR101536388B1 (en) |
| CN (2) | CN102656460B (en) |
| AU (1) | AU2010309931B2 (en) |
| BR (1) | BR112012005668A2 (en) |
| CA (1) | CA2776576C (en) |
| ES (1) | ES2628839T3 (en) |
| IL (1) | IL217934A (en) |
| MX (1) | MX337290B (en) |
| SG (1) | SG2014014823A (en) |
| WO (1) | WO2011048043A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9957331B2 (en) | 2009-10-19 | 2018-05-01 | Hoffmann-La Roche Inc. | Non-cross-reactive anti IgG antibodies |
| CA2806851C (en) * | 2010-08-17 | 2019-12-03 | F. Hoffmann-La Roche Ag | Anti-human igg1 antibody |
| CA2859268A1 (en) | 2012-02-01 | 2013-08-08 | F. Hoffmann-La Roche Ag | Method for the detection of a binding partner of a multispecific binder |
| EP2986990B1 (en) * | 2013-03-20 | 2018-08-15 | F.Hoffmann-La Roche Ag | Specific detection of rat antibodies in mouse serum |
| KR101654890B1 (en) * | 2013-07-10 | 2016-09-07 | 한국과학기술원 | Repebody Against Immunoglobulin G and Uses Thereof |
| MX2018005036A (en) | 2015-10-29 | 2018-08-01 | Hoffmann La Roche | Anti-variant fc-region antibodies and methods of use. |
| US11136609B2 (en) | 2015-11-09 | 2021-10-05 | National University Corporation Kyoto Institute Of Technology | Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same |
| EP3391050B1 (en) * | 2015-12-16 | 2020-09-16 | F. Hoffmann-La Roche AG | Three-step acid dissociation enzyme linked immunosorbent (tadelis) assay |
| CN109280644B (en) * | 2018-09-04 | 2023-02-17 | 四川安可瑞新材料技术有限公司 | Anti-human IgG monoclonal antibody, hybridoma cell strain and application thereof |
| CN109266620B (en) * | 2018-09-04 | 2023-01-10 | 四川安可瑞新材料技术有限公司 | Anti-human IgG monoclonal antibody, hybridoma cell strain and application thereof |
| CN109112113B (en) * | 2018-09-05 | 2023-01-10 | 四川安可瑞新材料技术有限公司 | Anti-human IgG monoclonal antibody, hybridoma cell strain, kit and application thereof |
| CN109082413B (en) * | 2018-09-18 | 2023-01-10 | 四川安可瑞新材料技术有限公司 | Anti-human IgG monoclonal antibody, hybridoma cell strain and application thereof |
| CN109112114B (en) * | 2018-09-18 | 2023-02-17 | 四川安可瑞新材料技术有限公司 | Anti-human IgG monoclonal antibody, hybridoma cell strain and application thereof |
| CN110483643B (en) * | 2018-09-19 | 2021-06-08 | 深圳市雅为泓源生物科技有限公司 | Novel antibody composition, isolated nucleic acid and preparation method |
| CN111190020B (en) * | 2020-01-20 | 2024-02-02 | 苏州药明康德新药开发有限公司 | Method for optimizing universal biological analysis by adding monkey serum |
| CN112010981B (en) * | 2020-09-10 | 2021-05-18 | 南京妙迪生物科技有限公司 | Mouse anti-human IgG monoclonal antibody |
| CN117858905A (en) | 2021-08-19 | 2024-04-09 | 豪夫迈·罗氏有限公司 | Multivalent anti-variant FC region antibodies and methods of use |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5332665A (en) | 1991-12-18 | 1994-07-26 | The General Hospital Corporation | Species specific, high affinity monoclonal antibodies |
| US5736137A (en) * | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| CN1180107A (en) * | 1996-06-18 | 1998-04-29 | 三井东压化学株式会社 | A monoclonal antibody, a cell line capable of producing the antibody and uses of the antibody |
| AR038568A1 (en) | 2002-02-20 | 2005-01-19 | Hoffmann La Roche | ANTI-A BETA ANTIBODIES AND ITS USE |
| EP1634606A1 (en) | 2003-03-31 | 2006-03-15 | Kyowa Hakko Kogyo Co., Ltd. | Drug for airway administration |
| US7378503B2 (en) | 2003-04-02 | 2008-05-27 | Hoffmann-La Roche Inc. | Antibodies against insulin-like growth factor 1 receptor and uses thereof |
| US7579157B2 (en) | 2003-07-10 | 2009-08-25 | Hoffmann-La Roche Inc. | Antibody selection method against IGF-IR |
| AR045614A1 (en) | 2003-09-10 | 2005-11-02 | Hoffmann La Roche | ANTIBODIES AGAINST THE RECEIVER OF INTERLEUQUINA- 1 AND USES OF THE SAME |
| CN1942483B (en) | 2004-04-13 | 2012-09-26 | 弗·哈夫曼-拉罗切有限公司 | Anti-P-selectin antibodies |
| KR100950635B1 (en) * | 2004-12-23 | 2010-04-01 | 에프. 호프만-라 로슈 아게 | Detection of therapeutic antibodies in experimental animals |
| TW200902555A (en) | 2005-01-03 | 2009-01-16 | Hoffmann La Roche | Antibodies against IL-13 receptor alpha 1 and uses thereof |
| CN101213450A (en) * | 2005-07-06 | 2008-07-02 | 霍夫曼-拉罗奇有限公司 | Detection of target antigen regardless of presence or absence of corresponding therapeutic antibody |
| WO2008031532A1 (en) * | 2006-09-12 | 2008-03-20 | F. Hoffmann-La Roche Ag | Anti-drug antibody assay |
| CN101506659B (en) * | 2006-09-12 | 2012-12-12 | 弗·哈夫曼-拉罗切有限公司 | Anti-drug antibody assay |
| TWI434855B (en) * | 2006-11-21 | 2014-04-21 | Hoffmann La Roche | Conjugate and its use as a standard in an immunoassay |
| US9957331B2 (en) | 2009-10-19 | 2018-05-01 | Hoffmann-La Roche Inc. | Non-cross-reactive anti IgG antibodies |
| CA2806851C (en) | 2010-08-17 | 2019-12-03 | F. Hoffmann-La Roche Ag | Anti-human igg1 antibody |
-
2010
- 2010-10-18 US US13/502,687 patent/US9957331B2/en active Active
- 2010-10-18 BR BR112012005668-9A patent/BR112012005668A2/en not_active Application Discontinuation
- 2010-10-18 ES ES10766278.5T patent/ES2628839T3/en active Active
- 2010-10-18 KR KR1020127010001A patent/KR101536388B1/en not_active Expired - Fee Related
- 2010-10-18 CA CA2776576A patent/CA2776576C/en not_active Expired - Fee Related
- 2010-10-18 AU AU2010309931A patent/AU2010309931B2/en not_active Ceased
- 2010-10-18 SG SG2014014823A patent/SG2014014823A/en unknown
- 2010-10-18 MX MX2012003825A patent/MX337290B/en active IP Right Grant
- 2010-10-18 WO PCT/EP2010/065617 patent/WO2011048043A1/en not_active Ceased
- 2010-10-18 CN CN201080047203.6A patent/CN102656460B/en active Active
- 2010-10-18 CN CN201610018354.8A patent/CN105624118B/en active Active
- 2010-10-18 EP EP10766278.5A patent/EP2491397B1/en active Active
- 2010-10-18 JP JP2012534646A patent/JP5715634B2/en active Active
-
2012
- 2012-02-05 IL IL217934A patent/IL217934A/en not_active IP Right Cessation
-
2014
- 2014-11-27 JP JP2014239470A patent/JP5894248B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012003825A (en) | 2012-05-08 |
| WO2011048043A1 (en) | 2011-04-28 |
| IL217934A0 (en) | 2012-03-29 |
| MX337290B (en) | 2016-02-24 |
| CN102656460B (en) | 2016-03-02 |
| EP2491397A1 (en) | 2012-08-29 |
| CN105624118A (en) | 2016-06-01 |
| CN105624118B (en) | 2019-08-13 |
| EP2491397B1 (en) | 2017-04-19 |
| KR20130026409A (en) | 2013-03-13 |
| CA2776576C (en) | 2018-01-02 |
| CA2776576A1 (en) | 2011-04-28 |
| JP5894248B2 (en) | 2016-03-23 |
| AU2010309931B2 (en) | 2015-08-20 |
| SG2014014823A (en) | 2014-07-30 |
| BR112012005668A2 (en) | 2020-10-13 |
| AU2010309931A1 (en) | 2012-03-01 |
| KR101536388B1 (en) | 2015-07-22 |
| ES2628839T3 (en) | 2017-08-04 |
| US20120208216A1 (en) | 2012-08-16 |
| US9957331B2 (en) | 2018-05-01 |
| JP2015070847A (en) | 2015-04-16 |
| JP2013508700A (en) | 2013-03-07 |
| CN102656460A (en) | 2012-09-05 |
| JP5715634B2 (en) | 2015-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL217934A0 (en) | NON-CROSS-REACTIVE ANTI IgG ANTIBODIES | |
| IL214996A0 (en) | Anti-bcma antibodies | |
| GB0920127D0 (en) | Antibodies | |
| GB0909906D0 (en) | Antibodies | |
| IL217919A0 (en) | Humanized anti-cdcp1 antibodies | |
| IL218724A0 (en) | Endoglin antibodies | |
| IL220404A (en) | Humanized antibodies | |
| ZA201104545B (en) | Anti-siglec-15 antibody | |
| PT3023438T (en) | Anti-gitr antibodies | |
| IL222852A0 (en) | Anti-fgfr2 antibodies | |
| GB201000467D0 (en) | Antibodies | |
| IL216147A0 (en) | Humanized axl antibodies | |
| ZA201202227B (en) | Monoclonal antibodies | |
| IL221371A0 (en) | Anti-lrp6 antibodies | |
| EP2427496A4 (en) | Anti-vegf-d antibodies | |
| GB201020738D0 (en) | Antibodies | |
| GB201002238D0 (en) | Antibodies | |
| GB0920324D0 (en) | Antibodies | |
| GB0905972D0 (en) | Antibodies against IL-17BR | |
| EP2499256A4 (en) | Anti-c-mpl antibodies | |
| IL214755A0 (en) | Anti-rhesus d monoclonal antibody | |
| GB2473934B (en) | Anti-VEEV antibody | |
| GB0908945D0 (en) | Antibodies | |
| GB0911712D0 (en) | Antibody | |
| GB201020751D0 (en) | Antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |